These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11009705)

  • 41. Hormone therapy: making decisions in the face of uncertainty.
    Peterson HB; Thacker SB; Corso PS; Marchbanks PA; Koplan JP
    Arch Intern Med; 2004 Nov; 164(21):2308-12. PubMed ID: 15557408
    [No Abstract]   [Full Text] [Related]  

  • 42. The estrogen paradox.
    Santen RJ; Allred DC
    Nat Clin Pract Endocrinol Metab; 2007 Jul; 3(7):496-7. PubMed ID: 17519914
    [No Abstract]   [Full Text] [Related]  

  • 43. Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60.
    Studd J
    Climacteric; 2009 Jun; 12(3):206-9. PubMed ID: 19437196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases].
    Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):321-3. PubMed ID: 12947970
    [No Abstract]   [Full Text] [Related]  

  • 45. Hormones and heart disease--down, not out.
    Harv Heart Lett; 2002 Mar; 12(7):3-5. PubMed ID: 11916632
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen replacement does not prevent recurrent stroke or death in postmenopausal women after an ischemic stroke.
    Basile JN
    J Clin Hypertens (Greenwich); 2002; 4(1):48-9. PubMed ID: 11821638
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
    Klein KP; Herrington DM
    Medscape Womens Health; 2002; 7(5):2. PubMed ID: 12466731
    [No Abstract]   [Full Text] [Related]  

  • 50. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review.
    Sherwin BB; Henry JF
    Front Neuroendocrinol; 2008 Jan; 29(1):88-113. PubMed ID: 17980408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guidelines offer women a change of heart. Focusing on prevention is the best way to halt heart disease in women.
    Harv Heart Lett; 2007 Jul; 17(11):3. PubMed ID: 17694610
    [No Abstract]   [Full Text] [Related]  

  • 52. [Estrogen use in systemic lupus erythematosus].
    Ketari S; Cherif O; Boussema F; Kochbati S; Ben Dhaou B; Rokbani L
    Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postmenopausal estrogen therapy not helpful for conditions of aging.
    Mayo Clin Womens Healthsource; 2004 Sep; 8(9):3. PubMed ID: 15295300
    [No Abstract]   [Full Text] [Related]  

  • 54. [Are estrogens carcinogens?].
    Emons G; Gründker C; Hanf V
    Zentralbl Gynakol; 2002 Dec; 124(12):559-65. PubMed ID: 12822069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ask the doctor: I started taking estrogen four years ago because I have a family history of heart disease and I have high cholesterol. Now I read that estrogen may even increase my risk for heart problems. I assume I should stop taking it, right?
    Lee TH
    Harv Heart Lett; 2000 Jul; 10(11):8. PubMed ID: 10877862
    [No Abstract]   [Full Text] [Related]  

  • 56. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postmenopausal estrogen use affects risk for Parkinson disease.
    Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF
    Arch Neurol; 2004 Jun; 61(6):886-8. PubMed ID: 15210525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone replacement therapy and thrombotic risk: beauty is only skin deep.
    Rosendaal FR
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):684-5. PubMed ID: 18797429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.